Cysmethynil
Tocris Bioscience, part of Bio-Techne | Catalog # 7337
ICMT inhibitor; arrests cell-cycle at G1 phase
Key Product Details
Description
ICMT inhibitor; arrests cell-cycle at G1 phase
Product Description
Cysmethynil is an isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor (IC50 = 2.4 μM). Cysmethynil reduces growth of RAS-mutant cell lines in vitro and in vivo (EC50 = 20 μM) and reduces cell viability in a variety of cell lines (IC50 = 16.8-23.3 μM). Tumor growth, mTOR signaling and cell proliferation are inhibited by cysmethynil; apoptosis is induced. Cysmethynil increases p27 and p21 proteins and arrests cell-cycle at the G1 phase.Product Specifications
Molecular Weight
376.54
Formula
C25H32N2O
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
5-(3-Methylphenyl)-1-octyl-1H-indole-3-acetamide
CAS Number
851636-83-4
PubChem ID
6918831
InChI Key
QIXBOOVPFRZHQQ-UHFFFAOYSA-N
SMILES
CCCCCCCCN1C=C(C2=CC(C3=CC(C)=CC=C3)=CC=C12)CC(N)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 18.83 | 50 | |
| Ethanol | 37.65 | 100 |
Preparing Stock Solutions
for Cysmethynil
The following data is based on the product molecular weight 376.54
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.66 mL | 13.28 mL | 26.56 mL |
| 5 mM | 0.53 mL | 2.66 mL | 5.31 mL |
| 10 mM | 0.27 mL | 1.33 mL | 2.66 mL |
| 50 mM | 0.05 mL | 0.27 mL | 0.53 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Manu Inhibition of isoprenylcysteine carboxylmethyltransferase induces cell-cycle arrest and apoptosis through p21 and p21-regulated BNIP3 induction in pancreatic cancer. Mol.Cancer Ther. 2017 PMID: 28167504
- Moore RAS-targeted therapies: is the undruggable drugged? Nat.Rev.Drug Discov. 2020 PMID: 32528145
Product Specific Notices for Cysmethynil
For research use only
Loading...
Loading...